Name: BTAI Balance Sheet - Bioxcel Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BTAI - Bioxcel Therapeutics, Inc.

USD | NASDAQ | Healthcare

BTAI Balance Sheet - Bioxcel Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash And Short Term Investments
Cash And Equivalents	28.4	29.9	65.2	193.7	233.0	213.1	32.4	42.6	0.9
Restricted Cash	28.8	0.0	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	28.4	29.9	65.2	193.7	233.0	213.1	32.4	42.6	0.9
Receivables
Accounts Receivable	0.2	0.1	0.1	0.2	-	-	-	-	-
Current Assets
Inventory	0.7	0.7	2.0	2.0	-	-	-	-	-
Prepaid Expenses	4.0	5.3	2.8	3.1	2.9
Non-Current Assets
Property, Plant & Equipment Gross	2.0	2.0	2.0	2.0	1.9	1.6	1.2	0.3	0.0
Accumulated Depreciation	1.8	1.5	1.2
Current Liabilities
Accounts Payable	14.7	16.0	13.7	10.2	4.7	4.0	5.0	1.6	0.4
Short Term Debt	24.9	0.0	-	-	-
Non-Current Liabilities
Long Term Debt	84.7	102.5	100.6	93.1	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.0	0.1	0.4	0.8
Common Equity
Common Stock	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional Paid In Capital	624.6	557.0	534.1	488.3	467.4
Supplementary Data
Total Debt	109.6	102.5	100.6	93.1	-	-	-	-	-
Net debt	81.2	72.7	35.4	(100.7)	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	17.2	28.4	36.2	17.4	31.0	29.9	40.4	56.3	74.1	65.2	90.0	127.5	165.5	193.7	232.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	0.5	0.7	0.5	0.5	0.6	0.7	1.5	2.7	2.4	2.0	2.0	1.9	2.0	2.0	1.4	1.4	0.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	3.9	4.0	5.7	5.2	4.7	5.3	4.5	2.8	2.1	2.8	3.9	3.7	4.5	3.1	5.5	8.4	5.0	2.9
Other Current Assets	12.1	10.9	0.9	1.0	1.4	1.4	1.4	1.6	1.9	2.1	2.2	4.6	5.0	3.8	2.4	1.7	1.5
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	33.9	44.7	44.4	25.2	37.8	37.4	47.8	64.2	80.9	72.1	98.7	138.2	177.3	202.9	241.7	244.9

Current Liabilities
Accounts Payable	16.2	14.7	16.3	16.7	15.5	16.0	14.9	13.3	17.2	13.7	10.7	11.2	7.7	10.2	5.9	6.0	5.1	4.7	3.4	2.5	5.3	4.0	8.6	10.4	6.7	5.0	4.2	4.0	2.1	1.6	1.2	0.9	3.9	-
Short Term Debt	22.4	24.9	16.8	11.2	5.6	0.0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	-	-	0.2	0.3	0.4	-	0.4	0.4	0.4	-	0.3	0.3	0.3	-	0.3	0.3
Accrued Expenses	6.4	4.3	4.4	5.1	4.0	5.8	10.2	13.5	13.7	12.4	26.6	19.1	17.1	18.7	13.9	13.4	10.6	11.5
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	0.8	0.5	0.5	0.4	0.4	0.3	0.3
Total Current Liabilities	55.0	53.9	37.8	33.4	25.5	22.2	25.6	27.3	31.5	27.3	39.4	34.7	28.8	32.9	23.4

Non-Current Liabilities
Long Term Debt	77.9	84.7	92.3	97.5	99.9	102.5	104.4	103.0	101.6	100.6	99.1	96.8	95.1	93.1	91.7	61.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	0.0	-	-	0.1	0.2	0.3	0.4	0.4	0.5	0.6	0.7	0.8	0.9	0.9
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	139.6	140.4	133.7	133.5	128.7	131.4	134.5	139.7	154.7	130.2	141.1	134.2	127.1	129.1	117.8	84.0

Common Equity
Common Stock	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	627.2	624.6	618.6	568.9	567.2	557.0	553.7	551.3	545.0	534.1	527.7	523.7	517.3	488.3	483.7	479.2	471.3
Retained Earnings	(732.8)	(720.1)	(707.5)	(676.6)	(657.5)	(650.2)	(639.3)	(625.7)	(617.4)	(590.6)	(568.3)	(517.9)	(464.3)	(411.5)	(356.7)	(314.9)	(277.3)
Accumulated Other Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	(105.5)	(95.5)	(88.9)	(107.7)	(90.2)	(93.1)	(85.6)	(74.3)	(72.4)	(56.5)	(40.6)	5.9	53.0	76.8	127.0	164.3	194.0
Total Equity	(105.5)	(95.5)	(88.9)	(107.7)	(90.2)	(93.1)	(85.6)	(74.3)	(72.4)	(56.5)	(40.6)	5.9	53.0	76.8	127.0	164.3	194.0	221.7

Supplementary Data
Total Debt	100.3	109.6	109.1	108.7	105.5	102.5	104.4	103.0	101.6	100.6	99.1	96.8	95.1	93.1	91.7	61.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	83.1	81.2	72.9	91.3	74.5	72.7	64.1	46.7	27.5	35.4	9.1	(30.7)	(70.5)	(100.7)	(140.6)	(172.4)	-	-
Working Capital	(21.1)	(9.2)	6.6	(8.1)	12.2	15.2	22.2	36.9	49.4	44.9	59.3	103.5	148.5	170.0	218.3	224.9	191.6	220.1
Book Value	(105.5)	(95.5)	(88.9)	(107.7)	(90.2)	(93.1)	(85.6)	(74.3)	(72.4)	(56.5)	(40.6)	5.9	53.0	76.8	127.0	164.3	194.0	221.7
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-